OTO-313 in Subjects With Subjective Tinnitus
Public ClinicalTrials.gov record NCT03918109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase 1/2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Subjective Tinnitus
Study identification
- NCT ID
- NCT03918109
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Otonomy, Inc.
- Industry
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Interventions
- OTO-313 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2019
- Primary completion
- May 28, 2020
- Completion
- May 28, 2020
- Last update posted
- Dec 22, 2022
2019 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| House Clinic | Los Angeles | California | 90057 | — |
| California Head & Neck Specialists | San Diego | California | 92121 | — |
| Colorado ENT and Allergy | Colorado Springs | Colorado | 80909 | — |
| Silverstein Institute/Ear Research Foundation | Sarasota | Florida | 34239 | — |
| ChicagoENT | Chicago | Illinois | 60657 | — |
| Advanced ENT and Allergy | Louisville | Kentucky | 40207 | — |
| Tandem Clinical Research, LLC | Marrero | Louisiana | 70072 | — |
| Summit Medical Group | Berkeley Heights | New Jersey | 10882 | — |
| Dent Neurosciences Research Center | Amherst | New York | 14226 | — |
| Northwell Health, Hearing & Speech Center | New Hyde Park | New York | 11042 | — |
| Northwell Health at ENT and Allergy Associates | White Plains | New York | 10605 | — |
| Charlotte Eye Ear Nose & Throat Associates | Charlotte | North Carolina | 28210 | — |
| Piedmont Ear, Nose, and Throat Associates | Winston-Salem | North Carolina | 27103 | — |
| Worldwide Clinical Trials | San Antonio | Texas | 78217 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| WVU Medicine | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03918109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2022 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03918109 live on ClinicalTrials.gov.